Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stille ABOSTO:STIL +2.56%100 FCF Margin % is 8.51% as of Jun. 2026, which is 5% below its 10-year median of 8.99. GuruFocus rates OSTO:STIL with a GF Score™ of 100/100 and a GF Value™ of kr257.17 (Fairly Valued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Stille AB ranks better than 62.58% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Stille AB's Free Cash Flow for the
three
months ended in Jun. 2026 was kr15.9 Mil. Stille AB's Revenue for the
three
months ended in Jun. 2026 was kr186.9 Mil. Therefore, Stille AB's FCF Margin % for the quarter that ended in Jun. 2026 was 8.51%.
The historical rank and industry rank for Stille AB's FCF Margin % or its related term are showing as below:
OSTO:STIL'
s FCF Margin % Range Over the Past 10 Years
Min: -6.28 Med: 8.99 Max: 18.57
Current: 4.88
During the past 13 years, the highest FCF Margin % of Stille AB was 18.57%. The lowest was -6.28%. And the median was 8.99%.
OSTO:STIL's FCF Margin % is ranked better than 62.58% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.83
vs OSTO:STIL: 4.88
The historical data trend for Stille AB's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:STIL vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Stille AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stille AB FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stille AB's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Stille AB's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stille AB (OSTO:STIL) has a FCF Margin % of 8.51% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Stille AB and its competitors. This is near median its historical median of 8.99. According to the industry distribution chart, Stille AB ranks #305 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 37.4%.
Is Stille AB's FCF Margin % too high?
Stille AB's current FCF Margin % of 8.51% is near median its 10-year median of 8.99. Based on the distribution chart, Stille AB ranks #305 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Stille AB has a GF Score™ of 100/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Stille AB's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Stille AB ranks #305 out of 815 companies for FCF Margin %. This puts Stille AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Stille AB and its competitors. Stille AB's current FCF Margin % is 8.51%, which is near median its own 10-year median of 8.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stille AB stock overvalued right now?
Based on GuruFocus' analysis, Stille AB (OSTO:STIL) is currently considered Fairly Valued. The stock's GF Value™ is kr257.17, compared to a current price of kr240.00 — trading 6.7% below its estimated fair value. The current FCF Margin % is 8.51%, which is near median its 10-year median of 8.99. Stille AB's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Stille AB (OSTO:STIL), the current FCF Margin % is 8.51% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stille AB (OSTO:STIL) Overvalued in 2026?
Based on GuruFocus' analysis, Stille AB stock appears to be undervalued.
The current stock price of kr240.00 is trading 6.7% below its estimated GF Value™ of kr257.17.
GuruFocus considers Stille AB to be Fairly Valued.
Key valuation signals for OSTO:STIL:
FCF Margin %: 8.51% (near median its 10-year median of 8.99)
GF Value™: kr257.17 vs. price of kr240.00 (6.7% below fair value)
No single metric tells the full story. See the OSTO:STIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stille AB manufactures and distributes medical devices. Its products include surgical equipment such as Surgical Scissors, Forceps, Curettes, Raspatories, Elevators, c-arm tables and instrument care education, among others.
100GF Score
Get the complete analysis for OSTO:STIL
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:STIL has been successfully added to your 
